Further evaluation of saline infusion for the diagnosis of primary aldosteronism

O. B. Holland, H. Brown, L. Kuhnert, C. Fairchild, M. Risk, C. E. Gomez-Sanchez

Research output: Contribution to journalArticle

124 Citations (Scopus)

Abstract

Normal subjects, normal-renin hypertensive patients, and low-renin hypertensive patients were evaluated by intravenous saline infusion and with a fludrocortisone acetate (Florinef) protocol to clarify diagnostic criteria for primary aldosteronism that are recommended for the saline infusion protocol. The patients consumed a 200 mEq sodium, 70 mEq potassium diet for 6 days, and on the last 3 days received Florinef 0.5 mg orally twice daily. On Days 3 and 6, urinary aldosterone and tetrahydroaldosterone excretions were determined, and on Days 4 and 7 plasma aldosterone (PA) was determined at 0600 after overnight recumbency and at 0800 after 2 hours of walking. Although the level of normal PA suppression by saline infusion has been commonly defined as 10 ng/dl, a value of 5 ng/dl was originally recommended. In 20 normal subjects and 45 normal-renin hypertensive patients, we found that the PA was almost always suppressed below 5 ng/dl. In 18 of 75 low-renin patients including five with aldosterone-producing adenoma (APA), the PA was never suppressed below 10 ng/dl; thus, these 18 patients had classical primary aldosteronism by generally accepted criteria. The Florinef protocol was performed in eight of these 18 patients and was abnormal in all. An abnormal Florinef protocol was also found in seven of 15 patients studied with PA suppression after saline infusion to between 5 and 10 ng/dl, but in only one of 24 patients studied with PA suppression below 5 ng/dl. Additional studies in the subgroup with abnormal results from the Florinef protocol indicated that none of these patients had evidence of APA, so they had nontumorous primary aldosteronism (NTPA). Thus, failure to suppress PA to less than 10 ng/dl with saline infusion is characteristic of patients with APA. However, the normal level should be lowered to 5 ng/dl when screening is done for NTPA. Additional studies such as Florinef suppression are necessary to gain confidence about the diagnosis of NTPA in those patients with PA suppression of between 5 and 10 ng/dl after saline infusion.

Original languageEnglish (US)
Pages (from-to)717-723
Number of pages7
JournalHypertension
Volume6
Issue number5
StatePublished - 1984

Fingerprint

Hyperaldosteronism
Aldosterone
Renin
Adenoma
fludrocortisone acetate
Intravenous Infusions
Walking
Potassium
Sodium

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Holland, O. B., Brown, H., Kuhnert, L., Fairchild, C., Risk, M., & Gomez-Sanchez, C. E. (1984). Further evaluation of saline infusion for the diagnosis of primary aldosteronism. Hypertension, 6(5), 717-723.

Further evaluation of saline infusion for the diagnosis of primary aldosteronism. / Holland, O. B.; Brown, H.; Kuhnert, L.; Fairchild, C.; Risk, M.; Gomez-Sanchez, C. E.

In: Hypertension, Vol. 6, No. 5, 1984, p. 717-723.

Research output: Contribution to journalArticle

Holland, OB, Brown, H, Kuhnert, L, Fairchild, C, Risk, M & Gomez-Sanchez, CE 1984, 'Further evaluation of saline infusion for the diagnosis of primary aldosteronism', Hypertension, vol. 6, no. 5, pp. 717-723.
Holland OB, Brown H, Kuhnert L, Fairchild C, Risk M, Gomez-Sanchez CE. Further evaluation of saline infusion for the diagnosis of primary aldosteronism. Hypertension. 1984;6(5):717-723.
Holland, O. B. ; Brown, H. ; Kuhnert, L. ; Fairchild, C. ; Risk, M. ; Gomez-Sanchez, C. E. / Further evaluation of saline infusion for the diagnosis of primary aldosteronism. In: Hypertension. 1984 ; Vol. 6, No. 5. pp. 717-723.
@article{5f92cc59f09244aaa44544f060baa16a,
title = "Further evaluation of saline infusion for the diagnosis of primary aldosteronism",
abstract = "Normal subjects, normal-renin hypertensive patients, and low-renin hypertensive patients were evaluated by intravenous saline infusion and with a fludrocortisone acetate (Florinef) protocol to clarify diagnostic criteria for primary aldosteronism that are recommended for the saline infusion protocol. The patients consumed a 200 mEq sodium, 70 mEq potassium diet for 6 days, and on the last 3 days received Florinef 0.5 mg orally twice daily. On Days 3 and 6, urinary aldosterone and tetrahydroaldosterone excretions were determined, and on Days 4 and 7 plasma aldosterone (PA) was determined at 0600 after overnight recumbency and at 0800 after 2 hours of walking. Although the level of normal PA suppression by saline infusion has been commonly defined as 10 ng/dl, a value of 5 ng/dl was originally recommended. In 20 normal subjects and 45 normal-renin hypertensive patients, we found that the PA was almost always suppressed below 5 ng/dl. In 18 of 75 low-renin patients including five with aldosterone-producing adenoma (APA), the PA was never suppressed below 10 ng/dl; thus, these 18 patients had classical primary aldosteronism by generally accepted criteria. The Florinef protocol was performed in eight of these 18 patients and was abnormal in all. An abnormal Florinef protocol was also found in seven of 15 patients studied with PA suppression after saline infusion to between 5 and 10 ng/dl, but in only one of 24 patients studied with PA suppression below 5 ng/dl. Additional studies in the subgroup with abnormal results from the Florinef protocol indicated that none of these patients had evidence of APA, so they had nontumorous primary aldosteronism (NTPA). Thus, failure to suppress PA to less than 10 ng/dl with saline infusion is characteristic of patients with APA. However, the normal level should be lowered to 5 ng/dl when screening is done for NTPA. Additional studies such as Florinef suppression are necessary to gain confidence about the diagnosis of NTPA in those patients with PA suppression of between 5 and 10 ng/dl after saline infusion.",
author = "Holland, {O. B.} and H. Brown and L. Kuhnert and C. Fairchild and M. Risk and Gomez-Sanchez, {C. E.}",
year = "1984",
language = "English (US)",
volume = "6",
pages = "717--723",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Further evaluation of saline infusion for the diagnosis of primary aldosteronism

AU - Holland, O. B.

AU - Brown, H.

AU - Kuhnert, L.

AU - Fairchild, C.

AU - Risk, M.

AU - Gomez-Sanchez, C. E.

PY - 1984

Y1 - 1984

N2 - Normal subjects, normal-renin hypertensive patients, and low-renin hypertensive patients were evaluated by intravenous saline infusion and with a fludrocortisone acetate (Florinef) protocol to clarify diagnostic criteria for primary aldosteronism that are recommended for the saline infusion protocol. The patients consumed a 200 mEq sodium, 70 mEq potassium diet for 6 days, and on the last 3 days received Florinef 0.5 mg orally twice daily. On Days 3 and 6, urinary aldosterone and tetrahydroaldosterone excretions were determined, and on Days 4 and 7 plasma aldosterone (PA) was determined at 0600 after overnight recumbency and at 0800 after 2 hours of walking. Although the level of normal PA suppression by saline infusion has been commonly defined as 10 ng/dl, a value of 5 ng/dl was originally recommended. In 20 normal subjects and 45 normal-renin hypertensive patients, we found that the PA was almost always suppressed below 5 ng/dl. In 18 of 75 low-renin patients including five with aldosterone-producing adenoma (APA), the PA was never suppressed below 10 ng/dl; thus, these 18 patients had classical primary aldosteronism by generally accepted criteria. The Florinef protocol was performed in eight of these 18 patients and was abnormal in all. An abnormal Florinef protocol was also found in seven of 15 patients studied with PA suppression after saline infusion to between 5 and 10 ng/dl, but in only one of 24 patients studied with PA suppression below 5 ng/dl. Additional studies in the subgroup with abnormal results from the Florinef protocol indicated that none of these patients had evidence of APA, so they had nontumorous primary aldosteronism (NTPA). Thus, failure to suppress PA to less than 10 ng/dl with saline infusion is characteristic of patients with APA. However, the normal level should be lowered to 5 ng/dl when screening is done for NTPA. Additional studies such as Florinef suppression are necessary to gain confidence about the diagnosis of NTPA in those patients with PA suppression of between 5 and 10 ng/dl after saline infusion.

AB - Normal subjects, normal-renin hypertensive patients, and low-renin hypertensive patients were evaluated by intravenous saline infusion and with a fludrocortisone acetate (Florinef) protocol to clarify diagnostic criteria for primary aldosteronism that are recommended for the saline infusion protocol. The patients consumed a 200 mEq sodium, 70 mEq potassium diet for 6 days, and on the last 3 days received Florinef 0.5 mg orally twice daily. On Days 3 and 6, urinary aldosterone and tetrahydroaldosterone excretions were determined, and on Days 4 and 7 plasma aldosterone (PA) was determined at 0600 after overnight recumbency and at 0800 after 2 hours of walking. Although the level of normal PA suppression by saline infusion has been commonly defined as 10 ng/dl, a value of 5 ng/dl was originally recommended. In 20 normal subjects and 45 normal-renin hypertensive patients, we found that the PA was almost always suppressed below 5 ng/dl. In 18 of 75 low-renin patients including five with aldosterone-producing adenoma (APA), the PA was never suppressed below 10 ng/dl; thus, these 18 patients had classical primary aldosteronism by generally accepted criteria. The Florinef protocol was performed in eight of these 18 patients and was abnormal in all. An abnormal Florinef protocol was also found in seven of 15 patients studied with PA suppression after saline infusion to between 5 and 10 ng/dl, but in only one of 24 patients studied with PA suppression below 5 ng/dl. Additional studies in the subgroup with abnormal results from the Florinef protocol indicated that none of these patients had evidence of APA, so they had nontumorous primary aldosteronism (NTPA). Thus, failure to suppress PA to less than 10 ng/dl with saline infusion is characteristic of patients with APA. However, the normal level should be lowered to 5 ng/dl when screening is done for NTPA. Additional studies such as Florinef suppression are necessary to gain confidence about the diagnosis of NTPA in those patients with PA suppression of between 5 and 10 ng/dl after saline infusion.

UR - http://www.scopus.com/inward/record.url?scp=0021750229&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021750229&partnerID=8YFLogxK

M3 - Article

C2 - 6389337

AN - SCOPUS:0021750229

VL - 6

SP - 717

EP - 723

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 5

ER -